Connect with us

Zynga Launches First-of-its-Kind Game of Thrones® Slots Casino

Published

on

Reading Time: 3 minutes

New Mobile Game Celebrates the Series with Stunning Visuals and Standout
Social Features

SAN FRANCISCO–(BUSINESS WIRE)–Today, Zynga
Inc.
(Nasdaq: ZNGA), a global leader in interactive entertainment,
announced that Game of Thrones Slots Casino has launched
globally on the App Store and Google Play, with versions for Facebook
and the Amazon Appstore coming soon. A new entry to Zynga’s social
casino portfolio, the game transports players to the realm of Westeros
for an authentic, social slots experience inspired by the acclaimed
Game of Thrones
television series from HBO®.


In Game of Thrones Slots Casino, players are immersed in
the epic drama, arresting dialogue, iconic characters and driving
musical themes of the series. From cliffhanger moments across the Seven
Kingdoms, to sweeping landscapes and locations like The Wall, the
best-in-class slots gameplay is infused with the fire and ice atmosphere
of Westeros and its most illustrious inhabitants, including Cersei,
Jaime, and Tyrion Lannister and House Stark members, Sansa, Arya, and
Jon Snow.

“As longtime fans of the series, Zynga is honored to contribute to the Game
of Thrones
universe, and honor-bound to provide players with an
experience that reflects the scale, scope, intensity, and community of
the series,” said Bernard Kim, President of Publishing at Zynga. “The
visual and audio design of the game truly evokes marquee moments from
the series, and with our House-themed social features, players can band
together to chase the throne themselves. Westeros lives on!”

Exciting social features and in-game chat in Game of Thrones Slots
Casino
allow players to band together to seek the seat of power
and all of its rewards. By joining or forming their own House, players
work with their brethren to rally through an interactive map of the
Seven Kingdoms. In the weekly ‘For the Throne’ challenge, Houses are
challenged to conquer each territory in turn, in a play to rule them
all. The player from the victorious House that stays on top until the
end of the challenge gains the right to sit atop the Iron Throne – until
a new challenger claims the crown.

Game Features:

  • Authentic Game of Thrones atmosphere. Slots casino gameplay is
    steeped with the sounds, characters, environments and ethos of
    Westeros, including unforgettable dialogue such as “Winter is coming.”
  • Best-in-class slots features. Spin on exciting, Game of
    Thrones
    -themed machines, featuring real-word mechanics like
    Progressive Jackpots, Bursting Wilds and more.
  • Join a House and reap the rewards. Gain advantages and rewards
    by joining or forming a House with other players, collecting coins for
    every housemate’s win.
  • Strategize, scheme, align. Connect and conspire with friends
    via the in-game chat at any time, even when spinning the slots.
  • Collect iconic cards. Spin to earn and level up cards featuring
    characters from the series, from the adventurous Arya Stark, to Jon
    Snow’s beloved companion wolf, Ghost. Collect all of the cards to earn
    a massive in-game reward.

Game of Thrones Slots Casino is now available for free
download on the App
Store
for iPhone and iPad and Google
Play
for Android devices. Visit www.gameofthronesslotscasino.com
for more information and follow Game of Thrones Slots Casino on
Instagram
and Facebook.

About Zynga Inc.

Zynga is a global leader in interactive entertainment with a mission to
connect the world through games. To date, more than one billion people
have played Zynga’s franchises including CSR Racing™, Empires
& Puzzles
™, Merge Dragons!™, Words With Friends™
and Zynga Poker™. Zynga’s games are available in more than 150
countries and are playable across social platforms and mobile devices
worldwide. Founded in 2007, the company is headquartered in San
Francisco with locations in the U.S., Canada, U.K., Ireland, India,
Turkey and Finland. For more information, visit www.zynga.com
or follow Zynga on Twitter
and Facebook.

About HBO Licensing & Retail

HBO Licensing & Retail, a division of Home Box Office, Inc., partners
with best-in-class licensees around the world to give HBO’s global
audience new and exciting ways to engage with their favorite shows. The
division leverages iconic, award-winning HBO programs such as Game of
Thrones, VEEP, Sex and the City, Silicon Valley, Insecure, The Sopranos,
Big Little Lies, True Blood
and more to create officially licensed
consumer products, innovative merchandise programs, retail activations
and live immersive experiences. HBO Licensing & Retail works across a
broad range of product categories, including collectibles, apparel,
publishing, live branded experiences, digital gaming, fashion and beauty
collaborations, luxury accessories, and beyond. Officially licensed HBO
merchandise can be purchased in retail stores around the world and
online in the US at http://store.hbo.com.

Contacts

Dana Whitney
dwhitney@zynga.com
| (415) 359-7006

Or

Kjell Vistad | Gilberto Williams-Gamboa
ONE PR Studio (for Zynga in
the US) / zynga@oneprstudio.com
/ (510) 893-3271

Cannabis

One Year of Medical Cannabis in the UK, Data by Grow Biotech

Published

on

Photo source: southeusummit.com

 

The 1st of November 2019 will mark the one year anniversary of the legalisation of medical cannabis in the United Kingdom. A year after Charlotte Caldwell’s tireless campaign to obtain life-saving medication for her son Billy catapulted medical cannabis onto the public agenda, the cost of prescriptions has dropped substantially while the number of scripts written has increased, but more needs to be done before it can be more widely offered by the National Health Service (NHS).

The average price of a month’s supply of medical cannabis imported through Logist has dropped from £750 to £550, reducing the average monthly prescription cost by 27%, while the average price per gram has also fallen by 25%. The reduction in cost is a combination of increased volume (meaning the costs associated with importing products is lower per prescription) and the increased availability of different products.

The type of medical specialist consultants writing prescriptions for medical cannabis has also diversified to include pain, oncology and neurology. There has also been a broadening in the delivery method for medical cannabis requested by specialist consultants to include different cannabis oils, pills and flowers, which is largely a result of the greater range of products available. Since February, Logist has imported approximately 1.5kg of flower to the UK.

The vast majority of medical cannabis has made its way to the UK thanks to Logist, a joint-venture formed between specials importer IPS Pharma, and Grow Biotech, the UK’s leading medical cannabis market access specialists.

Timeline of Events

  • 1st November 2018 – New regulations introduced, which allowed for the import and prescription of cannabis-based medicines
  • 14 February 2019 – The first bulk import of medical cannabis in the UK and first patients to receive medication from Logist
  • May 2019 – EU based bio-pharmaceutical company MGC Pharma appoints Logist
  • August 2019 – NICE publish interim report on medical cannabis
  • August 2019 – American medical cannabis giant Columbia Care announces that it will fund and provide medicine for clinical trials in the UK
  • September 2019– Leading Canadian company Aurora appoints IPS Pharma and Grow Biotech as importer and distributor for the UK market
  • September 2019 – Medical cannabis consultant informs Logist that a patient is no longer using opioids to manage their condition following treatment with medical cannabis

Looking forward to the near future, Chief Operating Officer of Grow Biotech, Hari Guliani, said, “Over the next twelve months we expect the UK’s medical community as a whole to take on the challenge of understanding how cannabis might help their patients. We are expecting leading consultants to publish papers on the impact they have seen on their patients, as well as evidence gathered through MHRA-approved trials. This will significantly improve the data available to regulators, policymakers and NICE.”

At present, it is only available on the NHS in extremely limited circumstances and is only obtainable through a prescription written by a specialist consultant in the private sector. NICE (The National Institute of Health Care Excellence) has advised that more clinical trials need to be undertaken in the UK and overall costs of medication need to be reduced before medical cannabis can be prescribed by NHS consultants. However, new medical trials are now underway and prices associated with the import of medical cannabis are falling dramatically, giving hope to the thousands of patients who are still struggling to access life-changing medication.

Another major change which cannot be overlooked is funding for the UK’s young medical cannabis industry. Ben Langley, Chief Executive Officer of Grow Biotech explained that, “We have seen a massive increase in funding for UK businesses operating within the medical cannabis space, especially from North America. In addition to the £5m Grow Biotech has raised over the last two years, there have been notably well received fundraises for Emmac Life Sciences PLC (£11m raised in March 2019) and for Oxford Cannabinoid Therapeutics ($10m in April 2019). This trend is likely to accelerate as European medical cannabis gradually establishes itself as an attractive asset class for global capital and European equity exchanges start to open their doors to cannabis companies.

Both Ben Langley and Hari Guliani are available for comment and interview.

 

SOURCE Grow Biotech

Continue Reading

Cannabis

GNCC Capital, Inc. – Pending Transaction

Published

on

 

GNCC Capital, Inc. (OTC: GNCP) (“The Company” or “GNCC”) advises that the new Board of Directors is in the process of consummating a further transaction in the Cannabis Sector and in South Africa.

Given that this is a related party transaction; they are awaiting ratification from an Independent party.

Upon consummation of this transaction; the new GNCC Directors will actively engage with shareholders. This decision was taken given that this transaction materially affects the size and scope of the Company’s South African Cannabis interests.

We reiterate that both Ms. Allen and Mr. Cox have recognized the need to; and have committed to expend the next two to three weeks in shareholder engagement. This is to ensure that all shareholders and investors become familiar with the Company’s new business operations, opportunities, Licensing and the Cannabis Industry in South Africa.

Forward-Looking Statements:-This press release may contain forward-looking statements. The words “believe,” “expect,” “should,” “intend,” “estimate,” “projects,” variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company’s current expectations and are subject to a number of risks, uncertainties and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company’s filings, which are on file with the OTC Markets Group.

SOURCE GNCC Capital, Inc.

Continue Reading

Cannabis

Empower Clinics Provides Corporate Updates Highlighting Triple Digit Patient Growth and Subsidiary Sun Valley Health Launches New Modalities and Patient Services

Published

on

 

EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented CBD life sciences company, a multi-state operator of medical health & wellness clinics, a CBD product producer and operator of an extraction facility in Oregon, is pleased to announce it is launching seven new modalities and services for patients in the Sun Valley Health clinics commencing Monday October 14th, 2019.

The Company also has patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 versus September 2018 with 614 patients seen.

“The tremendous year-over-year increase in patient visits is a testament to the operating strengths and patient management demonstrated by our clinic team members, each and every day,” said Steven McAuley, CEO of Empower. “Their passion for patient wellbeing and the use of numerous communication tools ensures world-class service is provided throughout the entire patient journey.”

As part of the Company’s continued expansion of our health & wellness clinic model, we have already set up retail CBD product sales in-clinic, and now we have launched expanded physician based services.

New Modalities and Services

  • Physician’s CBD Enhanced Massage, Acupuncture, or Cupping Sessions
  • CBD-Cannabis-Supplement Consumption & Coaching Consultation
  • Introduction to Alternative Health and Cannabinoid Therapies by a Physician
  • Comprehensive Naturopathic Patient Analysis & Consultation
  • Dietary Antigen Testing, Physician Consultation/Action Plan, & Concierge Blood Draw
  • Neurotransmitter (urine) Profile & Physician Consultation/Action Plan
  • Spectracell Micronutrient Test & Physician Consultation/Action Plan

“By offering our new suite of laboratory testing, alternative health consulting, and CBD therapies we are able to address the needs of our current patients and serve the community outside of cannabis that are seeking alternative health care,” states Dustin Klein, Director & VP Business Development. “Incorporating our new modalities, high quality vitamins, supplements, and CBD products into our network of clinics is a natural progression toward our goal of becoming the nation’s premier alternative healthcare provider.”

Additional UPDATES

  • New Modalities and Patient Services The Company continues to see patient visits in corporate clinics increase by triple digits, with September 2019 patients seen increasing by 307% to 1,884 over July 2018 614 patients seen.

  • Sun Valley Health Franchise Sun Valley Health www.sunvalleyhealth.com has been actively participating in various franchise and cannabis expos in St. LouisChicago and Houston to market the Sun Valley Health franchise program, attracting numerous qualified candidates for available territory locations. The Company has accepted many applications and has provided the Franchise Disclosure Document (FDD) to qualified applicants in anticipation of completing the first initial territory sales.

 

SOURCE Empower Clinics Inc.

Continue Reading

Trending Online

Grassnews is a news publishing website which digests / hand picks the latest news about the cannabis industry, and serves them to you daily.

Contact us: pressroom@grassnews.net

© Grassnews.net 2019 - part of PICANTE Media. All rights reserved. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania